The Board denied the Veteran's claim for service connection for T-cell lymphoma and mycosis fungoides, finding that there is no evidence linking his condition to military service in Djibouti.
The deciding factor: The VA examiner did not find a sufficient link between the Veteran's mycosis fungoides (T-cell lymphoma) and the HLTV virus prevalent in North or East Africa, where he served.
- Claimed conditions
- T-cell lymphoma, mycosis fungoides
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- March 18, 2023
- Citation
- 23016618
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 23016618.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Denied
The Veteran's claim for T-cell lymphoma was granted on a presumptive basis pursuant to the PACT Act, effective August 10, 2022. The earlier effective date is denied.,SMC based on housebound status was granted effective August 10, 2022, and an earlier effective date is not warranted.
- Whole decision: Denied
The Board denied the motion to revise or reverse a previous rating decision, finding that it was not clear and unmistakable error (CUE) for the April 2002 decision not to grant service connection for T-cell lymphoma from September 1996. The Veteran's earlier claim of peripheral neuropathy did not reasonably encompass T-cell lymphoma.
- Whole decision: Remanded (sent back)
The Board has determined that the February 2024 decision by the AOJ was legally inadequate due to a pre-decisional duty-to-assist error. The case is being remanded for further review and consideration of all relevant evidence, including medical opinions from the CEAT.
- Whole decision: Granted
The Veteran is granted an effective date of September 1, 2023, for the 100 percent disability rating of lymphomatoid papulosis, to include mycosis fungoides, and painful scarring (non-Hodgkin's lymphoma).
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.